Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression
PHASE3CompletedINTERVENTIONAL
Enrollment
120
Participants
Timeline
Start Date
June 30, 2002
Study Completion Date
August 31, 2002
Conditions
Major Depressive Disorder
Interventions
DRUG
Duloxetine
Trial Locations (9)
Unknown
Trumbull
Lafayette
Gaithersburg
Belmont
Omaha
Albuquerque
Staten Island
Salt Lake City
Bellevue
All Listed Sponsors
lead
Eli Lilly and Company
INDUSTRY
NCT00042575 - Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression | Biotech Hunter | Biotech Hunter